Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 23, 2017International Journal of CancerOpen Access

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

HVHege Marie VedeldNorwegian Cancer SocietyMMMarianne A. MerokAkershus University HospitalMJMarine JeanmouginOslo University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vedeld et al. (2017) studied this question.

synapsesocial.com/papers/6a9ec0cf9fb28041eca53642https://doi.org/10.1002/ijc.30796
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status2010 · 171 citations
  2. 2Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer2016 · 49 citations
  3. 3Methylation status in patients with early stage colon cancer: A new prognostic marker?2011 · 11 citations
  4. 4Clinicopathological features of CpG island methylator phenotype‐positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation2008 · 137 citations